BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 8978298)

  • 1. Measurement of spontaneous and therapeutic agent-induced apoptosis with BCL-2 protein expression in acute myeloid leukemia.
    Banker DE; Groudine M; Norwood T; Appelbaum FR
    Blood; 1997 Jan; 89(1):243-55. PubMed ID: 8978298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell cycle perturbations in acute myeloid leukemia samples following in vitro exposures to therapeutic agents.
    Banker DE; Groudine M; Willman CL; Norwood T; Appelbaum FR
    Leuk Res; 1998 Mar; 22(3):221-39. PubMed ID: 9619914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blasts from elderly acute myeloid leukemia patients are characterized by low levels of culture- and drug-induced apoptosis.
    Garrido SM; Cooper JJ; Appelbaum FR; Willman CL; Kopecky K; Banker DE
    Leuk Res; 2001 Jan; 25(1):23-32. PubMed ID: 11137557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flt3 ligand stimulates proliferation and inhibits apoptosis of acute myeloid leukemia cells: regulation of Bcl-2 and Bax.
    Lisovsky M; Estrov Z; Zhang X; Consoli U; Sanchez-Williams G; Snell V; Munker R; Goodacre A; Savchenko V; Andreeff M
    Blood; 1996 Nov; 88(10):3987-97. PubMed ID: 8916965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitation of resistance to cytosine arabinoside by myeloid leukemic cells expressing bcl-2.
    Guedez L; Suresh A; Tung F; Zucali J
    Eur J Haematol; 1996 Aug; 57(2):149-56. PubMed ID: 8856092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The t(8;21) translocation is not consistently associated with high Bcl-2 expression in de novo acute myeloid leukemias of adults.
    Banker DE; Radich J; Becker A; Kerkof K; Norwood T; Willman C; Appelbaum FR
    Clin Cancer Res; 1998 Dec; 4(12):3051-62. PubMed ID: 9865920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bcl-2 expression in acute myeloblastic leukaemia: relationship with autonomous growth and CD34 antigen expression.
    Bradbury DA; Zhu YM; Russell NH
    Leuk Lymphoma; 1997 Jan; 24(3-4):221-8. PubMed ID: 9156652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A flow cytometric method to detect apoptosis-related protein expression in minimal residual disease in acute myeloid leukemia.
    van Stijn A; Kok A; van der Pol MA; Feller N; Roemen GM; Westra AH; Ossenkoppele GJ; Schuurhuis GJ
    Leukemia; 2003 Apr; 17(4):780-6. PubMed ID: 12682637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute myeloid leukemia cells are protected from spontaneous and drug-induced apoptosis by direct contact with a human bone marrow stromal cell line (HS-5).
    Garrido SM; Appelbaum FR; Willman CL; Banker DE
    Exp Hematol; 2001 Apr; 29(4):448-57. PubMed ID: 11301185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 pathway in apoptosis induced by all-trans-retinoic acid in acute myeloblastic leukaemia cells.
    Zheng A; Mäntymaa P; Säily M; Savolainen E; Vähäkangas K; Koistinen P
    Acta Haematol; 2000; 103(3):135-43. PubMed ID: 10940651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD40L induces proliferation, self-renewal, rescue from apoptosis, and production of cytokines by CD40-expressing AML blasts.
    Aldinucci D; Poletto D; Nanni P; Degan M; Rupolo M; Pinto A; Gattei V
    Exp Hematol; 2002 Nov; 30(11):1283-92. PubMed ID: 12423681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Curcumin reduces expression of Bcl-2, leading to apoptosis in daunorubicin-insensitive CD34+ acute myeloid leukemia cell lines and primary sorted CD34+ acute myeloid leukemia cells.
    Rao J; Xu DR; Zheng FM; Long ZJ; Huang SS; Wu X; Zhou WH; Huang RW; Liu Q
    J Transl Med; 2011 May; 9():71. PubMed ID: 21595920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of Bcl-2-related genes in normal and AML progenitors: changes induced by chemotherapy and retinoic acid.
    Andreeff M; Jiang S; Zhang X; Konopleva M; Estrov Z; Snell VE; Xie Z; Okcu MF; Sanchez-Williams G; Dong J; Estey EH; Champlin RC; Kornblau SM; Reed JC; Zhao S
    Leukemia; 1999 Nov; 13(11):1881-92. PubMed ID: 10557066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diversity of the apoptotic response to chemotherapy in childhood leukemia.
    Liu T; Raetz E; Moos PJ; Perkins SL; Bruggers CS; Smith F; Carroll WL
    Leukemia; 2002 Feb; 16(2):223-32. PubMed ID: 11840289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraclonal heterogeneity in the in vitro daunorubicin-induced apoptosis in acute myeloid leukemia.
    Palucka KA; Knaust E; Xu D; Macnamara B; Porwit-Macdonald A; Gruber A; Peterson C; Björkholm M; Pisa P
    Leuk Lymphoma; 1999 Jan; 32(3-4):309-16. PubMed ID: 10037028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radotinib enhances cytarabine (Ara-C)-induced acute myeloid leukemia cell death.
    Heo SK; Noh EK; Yu HM; Kim DK; Seo HJ; Lee YJ; Cheon J; Koh SJ; Min YJ; Choi Y; Jo JC
    BMC Cancer; 2020 Dec; 20(1):1193. PubMed ID: 33276759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study of apoptosis-related responses of leukemic blast cells to in vitro anthracycline treatment.
    Belaud-Rotureau MA; Durrieu F; Labroille G; Lacombe F; Fitoussi O; Agape P; Marit G; Reiffers J; Belloc F
    Leukemia; 2000 Jul; 14(7):1266-75. PubMed ID: 10914552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytosine arabinoside (ara-C) resistance confers cross-resistance or collateral sensitivity to other classes of anti-leukemic drugs.
    Martin-Aragon S; Mukherjee SK; Taylor BJ; Ivy SP; Fu CH; Ardi VC; Avramis VI
    Anticancer Res; 2000; 20(1A):139-50. PubMed ID: 10769646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenylarsine oxide blocks interleukin-1beta-induced activation of the nuclear transcription factor NF-kappaB, inhibits proliferation, and induces apoptosis of acute myelogenous leukemia cells.
    Estrov Z; Manna SK; Harris D; Van Q; Estey EH; Kantarjian HM; Talpaz M; Aggarwal BB
    Blood; 1999 Oct; 94(8):2844-53. PubMed ID: 10515888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The anti-apoptotic genes Bcl-X(L) and Bcl-2 are over-expressed and contribute to chemoresistance of non-proliferating leukaemic CD34+ cells.
    Konopleva M; Zhao S; Hu W; Jiang S; Snell V; Weidner D; Jackson CE; Zhang X; Champlin R; Estey E; Reed JC; Andreeff M
    Br J Haematol; 2002 Aug; 118(2):521-34. PubMed ID: 12139741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.